Dr. Darrell George Vydra, DO

Dr. Vydra practices at Sweetwater Pain And Spine in Reno, Nevada.

Dr. Vydra's NPI, 1689945495, was assigned on January 25, 2012. Dr. Vydra graduated from William Carey University College of Osteopathic Medicine in 2017. Dr. Vydra holds Florida license OS17817.

Dr. Vydra's primary practice is Sweetwater Pain and Spine, at 10451 Double R Blvd, Reno, NV 89521. The practice phone is (775) 870-1480.

Dr. Vydra's primary practice is Sweetwater Pain And Spine in Reno, Nevada. Dr. Vydra is also affiliated with Renown Regional Medical Center. The medical group on file is Sweetwater Pain and Spine. Dmand AI also links Dr. Vydra to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vydra practices, 5 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Vydra's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dmand AI has Dr. Vydra's licenses on file in 2 states: Florida and Mississippi.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Vydra treats.

CMS data shows 26,246 Medicare services from Dr. Vydra across 31 procedure codes in 2024, for 383 Medicare patients. Medicare paid $165,252 for them. Every service was in an office.

CMS counts 383 Medicare patients who saw Dr. Vydra in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have arthritis, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vydra's median patient age at 66, with 61% women.

In 2024, Dr. Vydra wrote 1,071 Medicare Part D claims for 237 patients. 99% of them were for generic drugs. CMS names the drug for 999 of them, across 23 drugs with 11 or more claims each, at $18,787 in total drug cost. In 2023, CMS named 781 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Vydra for performance year 2024, reported individually. Dr. Vydra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Vydra in 2019. The most frequent topics are Injections, Epidural, Injections, Spinal and Lumbar Vertebrae. Dr. Vydra has published most often in Pain Med. Dr. Vydra's most frequent co-authors are Daniel Matthew Cushman, MD, Ameet S. Nagpal, MD, MS and Alexander Thomas Hynes, DO.

CMS Open Payments shows 79 general payments to Dr. Vydra from 14 drug and device companies from 2021 to 2025. Grants make up the largest share, 60% of the total. Medtronic, Inc. paid the most, $5,477.

Dmand AI lists 4 awards for Dr. Vydra, most recently Best Overall Quality Improvement Project for the manuscript titled “Measuring Acute Medical Discharge from an Inpatient Rehabilitation Medicine Service” in 2021.

Dr. Vydra graduated from William Carey University College of Osteopathic Medicine in 2017.

Dr. Vydra is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.